BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11587378)

  • 1. Alexander disease and intermediate filaments in astrocytes: a fatal gain of function.
    Jaeken J
    Eur J Paediatr Neurol; 2001; 5(4):151-3. PubMed ID: 11587378
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel deletion mutation in GFAP gene in an infantile form of Alexander disease.
    Murakami N; Tsuchiya T; Kanazawa N; Tsujino S; Nagai T
    Pediatr Neurol; 2008 Jan; 38(1):50-2. PubMed ID: 18054694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Glial fibrillary acidic protein: the component of intermediate filaments in the vertebrate brain astrocytes].
    Sukhorukova EG; Kruzhevskiĭ DÉ; Alekseeva OS
    Zh Evol Biokhim Fiziol; 2015; 51(1):3-10. PubMed ID: 25859599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Murine model of Alexander disease: analysis of GFAP aggregate formation and its pathological significance.
    Tanaka KF; Takebayashi H; Yamazaki Y; Ono K; Naruse M; Iwasato T; Itohara S; Kato H; Ikenaka K
    Glia; 2007 Apr; 55(6):617-31. PubMed ID: 17299771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GFAP and its role in Alexander disease.
    Quinlan RA; Brenner M; Goldman JE; Messing A
    Exp Cell Res; 2007 Jun; 313(10):2077-87. PubMed ID: 17498694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astrocytes cultured from transgenic mice carrying the added human glial fibrillary acidic protein gene contain Rosenthal fibers.
    Eng LF; Lee YL; Kwan H; Brenner M; Messing A
    J Neurosci Res; 1998 Aug; 53(3):353-60. PubMed ID: 9698163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Astrocyte intermediate filaments in CNS pathologies and regeneration.
    Pekny M; Pekna M
    J Pathol; 2004 Nov; 204(4):428-37. PubMed ID: 15495269
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene expression analysis in mice with elevated glial fibrillary acidic protein and Rosenthal fibers reveals a stress response followed by glial activation and neuronal dysfunction.
    Hagemann TL; Gaeta SA; Smith MA; Johnson DA; Johnson JA; Messing A
    Hum Mol Genet; 2005 Aug; 14(16):2443-58. PubMed ID: 16014634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is Alexander's disease a nosologic entity or a common pathologic pattern of diverse etiology?
    Herndon RM
    J Child Neurol; 1999 May; 14(5):275-6. PubMed ID: 10342592
    [No Abstract]   [Full Text] [Related]  

  • 10. Cytoskeletal catastrophe causes brain degeneration.
    Quinlan R
    Nat Genet; 2001 Jan; 27(1):10-1. PubMed ID: 11137988
    [No Abstract]   [Full Text] [Related]  

  • 11. Vimentin-positive astrocytes in canine distemper: a target for canine distemper virus especially in chronic demyelinating lesions?
    Seehusen F; Orlando EA; Wewetzer K; Baumgärtner W
    Acta Neuropathol; 2007 Dec; 114(6):597-608. PubMed ID: 17965866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alexander disease with occipital predominance and a novel c.799G>C mutation in the GFAP gene.
    Hinttala R; Karttunen V; Karttunen A; Herva R; Uusimaa J; Remes AM
    Acta Neuropathol; 2007 Nov; 114(5):543-5. PubMed ID: 17805552
    [No Abstract]   [Full Text] [Related]  

  • 13. [Generation of mice with glial cell dysfunction].
    Tanaka K; Lee HU; Ikenaka K
    Brain Nerve; 2007 Jul; 59(7):747-53. PubMed ID: 17663146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cytoskeleton and differentiation. Genetic regulation of intermediate filaments in the neuromuscular system].
    Li Z; Humbert J; Lilienbaum A; Vicart P; Paulin D
    Arch Inst Pasteur Tunis; 1994; 71(3-4):419-30. PubMed ID: 8801837
    [No Abstract]   [Full Text] [Related]  

  • 15. Astrocyte-specific overexpression of insulin-like growth factor-I promotes brain overgrowth and glial fibrillary acidic protein expression.
    Ye P; Popken GJ; Kemper A; McCarthy K; Popko B; D'Ercole AJ
    J Neurosci Res; 2004 Nov; 78(4):472-84. PubMed ID: 15468174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GFAP at 50.
    Messing A; Brenner M
    ASN Neuro; 2020; 12():1759091420949680. PubMed ID: 32811163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GFAP: functional implications gleaned from studies of genetically engineered mice.
    Messing A; Brenner M
    Glia; 2003 Jul; 43(1):87-90. PubMed ID: 12761871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glial fibrillary acidic protein mutations in infantile, juvenile, and adult forms of Alexander disease.
    Li R; Johnson AB; Salomons G; Goldman JE; Naidu S; Quinlan R; Cree B; Ruyle SZ; Banwell B; D'Hooghe M; Siebert JR; Rolf CM; Cox H; Reddy A; Gutiérrez-Solana LG; Collins A; Weller RO; Messing A; van der Knaap MS; Brenner M
    Ann Neurol; 2005 Mar; 57(3):310-26. PubMed ID: 15732097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Focus on molecules: glial fibrillary acidic protein (GFAP).
    Sarthy V
    Exp Eye Res; 2007 Mar; 84(3):381-2. PubMed ID: 16563382
    [No Abstract]   [Full Text] [Related]  

  • 20. GFAP promoter elements required for region-specific and astrocyte-specific expression.
    Lee Y; Messing A; Su M; Brenner M
    Glia; 2008 Apr; 56(5):481-93. PubMed ID: 18240313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.